glutamine has been researched along with Lymphoma, Mantle-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Che, Y; Chen, Z; Jiang, VC; Jordan, A; Leeming, A; Li, L; Li, Y; Liu, Y; Nie, L; Vargas, J; Wang, M; Wang, W; Yao, Y | 1 |
| Fujimura, T; Isobe, Y; Kaga, N; Komatsu, N; Miyazono, K; Ono, A; Sasaki, M; Sugimoto, K; Suzuki, HI; Taka, H | 1 |
2 other study(ies) available for glutamine and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Topics: Adult; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutaminase; Glutamine; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local | 2023 |
A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
Topics: Antineoplastic Agents; Asparaginase; Cell Line, Tumor; Chromatography, Gas; Flow Cytometry; Glutamine; Humans; Jurkat Cells; Lymphoma, Mantle-Cell; Mass Spectrometry; Membrane Potential, Mitochondrial; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2015 |